Royalty Pharma
RPRX
#761
Rank
HK$259.35 B
Marketcap
HK$450.41
Share price
0.25%
Change (1 day)
61.91%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: HK$259.35 Billion

As of July 2026 Royalty Pharma has a market cap of HK$259.35 Billion. This makes Royalty Pharma the world's 761th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$259.35 B45.74%
2025HK$177.95 B52.33%
2024HK$116.82 B-11.19%
2023HK$131.53 B-3.42%
2022HK$136.20 B2.05%
2021HK$133.46 B-11.38%
2020HK$150.59 B

End of Day market cap according to different sources

On Jul 20th, 2026 the market cap of Royalty Pharma was reported to be:

HK$258.70 Billion
by Nasdaq info icon info icon
HK$258.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
HK$1.365 T 426.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$8.126 T 3,033.44%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
HK$13.88 B-94.65%๐Ÿ‡บ๐Ÿ‡ธ USA